Beacon Pharmaceuticals PLC (DSE:BEACONPHAR)
118.40
-0.20 (-0.17%)
At close: Apr 17, 2025
Beacon Pharmaceuticals Cash Flow Statement
Financials in millions BDT. Fiscal year is July - June.
Millions BDT. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | 2015 - 2019 |
Net Income | 570.05 | 521.01 | 509.84 | 935.04 | 863.17 | 380.69 | Upgrade
|
Depreciation & Amortization | 527.78 | 527.78 | 518.92 | 439.7 | 385.16 | 511.01 | Upgrade
|
Loss (Gain) From Sale of Assets | 6.5 | 6.5 | -3.07 | - | - | - | Upgrade
|
Other Operating Activities | 2,252 | 287.23 | -147.1 | 438.72 | 75.87 | -243.62 | Upgrade
|
Change in Accounts Receivable | -767.59 | -767.59 | -251.01 | -30.72 | -873.78 | -357.19 | Upgrade
|
Change in Inventory | -895.97 | -895.97 | -19.73 | -693.28 | -246.07 | -28.33 | Upgrade
|
Change in Accounts Payable | 680.87 | 680.87 | 191.87 | -7.83 | 183.53 | -8.58 | Upgrade
|
Change in Income Taxes | - | - | - | -169.84 | 162.23 | -64.93 | Upgrade
|
Change in Other Net Operating Assets | -539.46 | -539.46 | -178.55 | 170.39 | -353.56 | 102.09 | Upgrade
|
Operating Cash Flow | 1,834 | -179.63 | 621.18 | 1,082 | 196.56 | 291.14 | Upgrade
|
Operating Cash Flow Growth | - | - | -42.60% | 450.56% | -32.49% | 32.08% | Upgrade
|
Capital Expenditures | -318.69 | -1,095 | -1,814 | -1,719 | -313.41 | -313.94 | Upgrade
|
Sale of Property, Plant & Equipment | 30.29 | 30.15 | - | - | - | - | Upgrade
|
Sale (Purchase) of Intangibles | -25.22 | -25.22 | - | - | - | - | Upgrade
|
Investment in Securities | -1,936 | -1,276 | -2,190 | -118.52 | -403.71 | -0.82 | Upgrade
|
Other Investing Activities | -7.26 | -0 | 39.83 | - | 3.24 | 1.31 | Upgrade
|
Investing Cash Flow | -2,257 | -2,366 | -3,965 | -1,838 | -713.87 | -313.46 | Upgrade
|
Short-Term Debt Issued | - | - | - | 1,529 | 349.06 | 473.1 | Upgrade
|
Long-Term Debt Issued | - | 2,864 | 3,628 | - | - | - | Upgrade
|
Total Debt Issued | 702.26 | 2,864 | 3,628 | 1,529 | 349.06 | 473.1 | Upgrade
|
Long-Term Debt Repaid | - | - | - | -199.71 | -33.27 | -76.68 | Upgrade
|
Total Debt Repaid | -252.18 | - | - | -199.71 | -33.27 | -76.68 | Upgrade
|
Net Debt Issued (Repaid) | 450.08 | 2,864 | 3,628 | 1,330 | 315.79 | 396.43 | Upgrade
|
Common Dividends Paid | -739.32 | -369.56 | -371.06 | -373.53 | -59.42 | -57.99 | Upgrade
|
Financing Cash Flow | -289.24 | 2,494 | 3,257 | 956.25 | 256.37 | 338.44 | Upgrade
|
Foreign Exchange Rate Adjustments | -147.17 | -93.69 | - | - | - | - | Upgrade
|
Miscellaneous Cash Flow Adjustments | 0 | - | - | - | - | - | Upgrade
|
Net Cash Flow | -859.36 | -145.24 | -86.31 | 200.66 | -260.94 | 316.13 | Upgrade
|
Free Cash Flow | 1,516 | -1,275 | -1,193 | -637.07 | -116.85 | -22.8 | Upgrade
|
Free Cash Flow Margin | 13.09% | -11.91% | -14.02% | -7.94% | -1.64% | -0.41% | Upgrade
|
Free Cash Flow Per Share | 6.56 | -5.52 | -5.17 | -2.76 | -0.51 | -0.10 | Upgrade
|
Cash Interest Paid | 1,211 | 983.91 | 464.36 | 339.38 | 166.8 | 150.27 | Upgrade
|
Cash Income Tax Paid | 476.43 | 257.56 | 271.77 | 450.75 | 17.31 | 20 | Upgrade
|
Levered Free Cash Flow | 1,788 | -3,102 | -3,814 | -1,146 | -562.04 | -229.56 | Upgrade
|
Unlevered Free Cash Flow | 2,590 | -2,475 | -3,526 | -934.37 | -459.03 | -136.24 | Upgrade
|
Change in Net Working Capital | -1,037 | 3,026 | 2,843 | 665.62 | 1,382 | 541.73 | Upgrade
|
Updated Feb 3, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.